Sophia Tsoka
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 23, 2026
Mapping Molecular Transitions in Barrett's-Associated Oesophageal Adenocarcinoma via Multi-Omics Integration and Pathway Activity Modelling.
Journal: Cancers
Published: April 30, 2026
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 09, 2026
SCONE: a subset-contrastive method for multi-omics network embedding.
Journal: Briefings in bioinformatics
Published: November 06, 2025
Immunophenotyping TCF1-expressing TILs: spatial profiling and prognostic value in operable non-small cell lung cancer.
Journal: Frontiers in immunology
Published: October 24, 2025
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer.
Journal: NPJ precision oncology
Published: August 31, 2025
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: a scoping review.
Journal: The British journal of dermatology
Published: August 15, 2025
Deep Contrastive Learning for High-Throughput Prediction of Drug Resistance Mutations from Sequences.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 05, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.
Journal: Journal for immunotherapy of cancer
Published: May 13, 2025
Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use.
Journal: International journal of pharmaceutics
Published: March 20, 2025
Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors.
Journal: Journal for immunotherapy of cancer
Published: January 15, 2025
Last Updated: 09/26/2026